The prevalence of and reasons for interruption of anti-tuberculosis treatment by patients at Mbekweni Health Centre in King Sabata Dalindyebo (KSD) District in the Eastern Cape province

South African Family Practice

Volumn 50, Issue 6, 2008, Pages

  Kandel, T R ^a   Mfenyana, K ^a   Chandia, J ^a   Yogeswaran, P ^a  

^a WALTER SISULU UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE ACCESS; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICAL DISABILITY; PREVALENCE; RESOURCE ALLOCATION; SOCIOECONOMICS; SOUTH AFRICA; TUBERCULOSIS;

EID: 60249097770     PISSN: 20786190     EISSN: 20786204     Source Type: Journal    
DOI: 10.1080/20786204.2008.10873785     Document Type: Article

References (26)

1. The South African Tuberculosis Control Program. Tuberculosis: A training manual for health workers. 1st edition. 1998. Department of Health - Directorate of Tuberculosis Control, Pretoria, South Africa.
2. Global Tuberculosis Report 2007. World Health Organisation, Geneva, Switzerland.http://www.who.int/tb/publicationsgloba_report/2007/pdf (Accessed 04/06/2007).
3. Gole ST, Brosch R, Parkhill J, et al. Deciphering the biology of mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393:537-44.
4. Yutang M, Stern RJ, Scherman MS, et al. Drug targeting mycobacterium tuberculosis cell wall synthesis: genetics of dTDp rhamnose synthetic enzymes and development of a microtiter plate based screen for inhibitors of conversion of dTDp- glucose to dTP- rhamnose. Antimicrobe agents chemother 2001; 45:1407-16.
5. Duncan K. The impact of genomics on the search for novel tuberculosis drugs. Genetics and tuberculosis. Chichester: wiley (Novartis foundation symposium 217); 1998.228-38.
6. Zhang Y, Amzer LM, Tuberculosis drug targets. Curr Drug targets 2002;3:131-54.
7. WHO. Bulletin of the World Health Organization. Int J Public Health 2002;80:426-523.
8. WHO. Risk factors for tuberculosis. The World Health report, World Health Organization, Geneva, Switzerland, 2003. p 77.
9. ResolutionWHA44.853WorldHealthAssembly. http://ftp.who.int/gb/pdf_files/ WHA53/ea5.pdf (Accessed 05/06/2007).
10. Narain JP, Raviglione MC, Kochi A. HIV associated tuberculosis in developing countries: Epidemiology and strategies for prevention. Tuberc lung dis 1992;73:311-321.
11. Jeena P M. The interaction of HIV and tuberculosis in childhood. S Afr Med J. 2007: 97(10):989-91.
12. WHO. Tuberculosis. Fact sheet 104. World Health Organization, Geneva: 2002.. http/www.who.int/medicentre/factsheets/who104/en/index.html. (Accessed 12/12/2002).
13. WHO Report 2007. Global tuberculosis control. World Health Organization, Geneva, Switzerland. http://www.who.int/globalatlas/predefinedReports/TB/ zaf.pdf (Accessed 04/06/2007).
14. Global Tuberculosis Control Surveillance, Planning, Finance. WHO/HTM/TB/ 2007.376,WHO Report 2007.World Health Organization, Geneva, Switzerland, 2007.
15. Weyer K, Fourie PB Nardell EA. A Noxious Synergy: Tuberculosis and HIV in South Africa. The Global Impact of Drug - Resistant Tuberculosis. Harvard Medical School and Open Society Institute, Boston, USA, 1999.
16. TB in South Africa still a major problem. Strides and struggles in TB control. Advocacy Department, National TB Control Program, National Department of Health, Pretoria, South Africa, Annual report 1997-1998;1-32.
17. Editor. The South African TB, Khomani News, Houghton 2041, South Africa. Volume 10, March 2006.
18. Mahlalela X, Rohde J, Bennett J. The status of primary health care services in the Eastern Cape province. Report on the 1st equity primary health care survey of clinics and district hospitals of the Eastern Cape province, S A.1997. MSH/EQUITY Project. October 1998.
19. Meidany F, Puchert R. Eastern Cape Epidemiological notes. Department of Health, Province of the Eastern Cape. South Africa 1999 Jul 7(3).
20. AL-Hajjaj MS, AL-Katim I.M. High rate of non-compliance with anti-tuberculosis treatment despite a retrieval syste: A call for implementation of direct observed therapy in Soudi Arabia. Int J Tuberc Lung Dis 2000 Apr;4(4):345-9.
21. Williams KE, Bond MJ. The roles of self-efficacy, outcome expectancies and social support in the self care behaviors of diabetics. Psychol, Health and Med 2002;7:127-41.
22. Kaona FA, Tuba M, Siziya S. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. V.41:2004. (Accessed 18/03/2008).
23. Chee C, Boudville I, Chan S, Zee Y, Wang Y. Patient and disease characteristics and out come of treatment defaulters from the Singapore TB control unit-a one year retrospective survey. Int J Tuberc Lung Dis. 2000 Jun;4(6):496-503.
24. Dick J, Lewin S, Rose E, Zwarenstein M, Walt H. Changing professional practice in tuberculosis care: an educational intervention. J Adv Nurs. 2004 Dec; 48(5):434-42.
25. Connolly C, Davies GR, Wilkinson D. Who fails to complete tuberculosis treatment? Temporal trends and risk factors for treatment interruption in a community-based directly observed therapy program in a rural district of South Africa. Int J Tuberc Lung Dis.1999 Dec;3(12):1081-7.
26. Bamford L, Loveday M, Verkuijl S. Tuberculosis. South African health review. Health systems trust, Durban, South Africa. 2004. p 213-228.